Last updated: 14 August 2024 at 5:12pm EST

John Minardo Net Worth




The estimated Net Worth of Minardo John is at least 2.35 百万$ dollars as of 12 August 2024. Mr John owns over 9,910 units of Ironwood Pharmaceuticals Inc stock worth over 1,238,275$ and over the last 3 years he sold IRWD stock worth over 1,109,727$.

Mr Minardo IRWD stock SEC Form 4 insiders trading

Mr has made over 7 trades of the Ironwood Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 9,910 units of IRWD stock worth 42,316$ on 12 August 2024.

The largest trade he's ever made was selling 47,380 units of Ironwood Pharmaceuticals Inc stock on 12 February 2024 worth over 722,071$. On average, Mr trades about 11,683 units every 66 days since 2021. As of 12 August 2024 he still owns at least 284,661 units of Ironwood Pharmaceuticals Inc stock.

You can see the complete history of Mr John stock trades at the bottom of the page.





Mr. John Minardo biography

John Minardo is the Sr. VP & Chief Legal Officer at Ironwood Pharmaceuticals Inc.



What's Mr Minardo's mailing address?

Minardo's mailing address filed with the SEC is C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110.

Insiders trading at Ironwood Pharmaceuticals Inc

Over the last 15 years, insiders at Ironwood Pharmaceuticals Inc have traded over 83,928,361$ worth of Ironwood Pharmaceuticals Inc stock and bought 2,478,676 units worth 24,100,589$ . The most active insiders traders include Llc FmrBryan E RobertsAlexander J Denner. On average, Ironwood Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of 239,611$. The most recent stock trade was executed by Minardo John on 12 August 2024, trading 9,910 units of IRWD stock currently worth 42,316$.



What does Ironwood Pharmaceuticals Inc do?

ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b



What does Ironwood Pharmaceuticals Inc's logo look like?

Ironwood Pharmaceuticals Inc logo

Complete history of Mr John stock trades at Ironwood Pharmaceuticals Inc

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
12 Aug 2024 Minardo John
Chief Legal Officer
販売 9,910 4.27$ 42,316$
12 Aug 2024
284,661
20 May 2024 Minardo John
Chief Legal Officer
販売 17,404 6.45$ 112,256$
20 May 2024
294,571
8 Mar 2024 Minardo John
Chief Legal Officer
オプション行使 32,752 9.01$ 295,096$
8 Mar 2024
311,975
12 Feb 2024 Minardo John
Chief Legal Officer
販売 47,380 15.24$ 722,071$
12 Feb 2024
224,796
14 Aug 2023 Minardo John
Chief Legal Officer
販売 7,045 10.04$ 70,732$
14 Aug 2023
192,195
27 Feb 2023 Minardo John
Chief Legal Officer
販売 6,697 11.36$ 76,078$
27 Feb 2023
133,738
15 Aug 2022 Minardo John
Chief Legal Officer
販売 7,330 11.77$ 86,274$
15 Aug 2022
140,435


Ironwood Pharmaceuticals Inc executives and stock owners

Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include: